Definitions
from The American Heritage® Dictionary of the English Language, 5th Edition.
- noun A synthetic antibiotic, C13H17N5O8S2, that acts against a wide spectrum of gram-negative bacteria.
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
synthetic monobactam originallyisolated from Chromobacterium violaceum, similar in action topenicillin .
from WordNet 3.0 Copyright 2006 by Princeton University. All rights reserved.
- noun an antibiotic (trade name Azactam) used against severe infections; has minimal side effects
Etymologies
from The American Heritage® Dictionary of the English Language, 4th Edition
Support
Help support Wordnik (and make this page ad-free) by adopting the word aztreonam.
Examples
-
In the EU, Cayston is referred to as aztreonam lysine 75 mg powder for nebuliser solution and can only be used with the Altera Nebuliser System or with the Altera Nebuliser Handset
-
• On September 23, GILD received conditional marketing approval from European regulators to market Cayston (formerly known as aztreonam), a treatment for chronic lung infection in cystic fibrosis patients whose dosing regimen calls for 3x/day for 28 days.
-
The monobactams, developed in the 1980s, which include aztreonam.
SUPERBUG MARYN MCKENNA 2010
-
The monobactams, developed in the 1980s, which include aztreonam.
SUPERBUG MARYN MCKENNA 2010
-
The monobactams, developed in the 1980s, which include aztreonam.
SUPERBUG MARYN MCKENNA 2010
-
The particular strain of NDM-1 could be treated only by a single drug, aztreonam; it was resistant to everything else.
Wired Top Stories Maryn McKenna 2011
-
Sciences (GILD) announced that the US FDA granted marketing approval for Cayston, or aztreonam for inhalation solution, as a treatment to improve respiratory symptoms in cystic fibrosis, or
-
Gilead Sciences (GILD) announced that the US FDA granted marketing approval for Cayston, or aztreonam for inhalation solution, as a treatment to improve respiratory symptoms in cystic fibrosis, or CF, patients with Pseudomonas aeruginosa
-
Gilead submitted Cayston, a reformulated version of the intravenous antibiotic aztreonam lysine, for Food and Drug Administration approval in November 2007.
Philadelphia Business News - Local Philadelphia News | The Philadelphia Business Journal 2010
-
In terms of the numbers that we generated relative to non-inferiority assessments, those are really right on top of vancomycin and aztreonam combination as it relates to the skin results.
Healthcare Sector and Stocks Analysis from Seeking Alpha 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.